GRB2-associated-binding protein 2 (GAB2) mRNA 3'-untranslated region (GAB2 mRNA 3'-UTR)

The GRB2-associated-binding protein 2 (GAB2) mRNA 3'-untranslated region (3'-UTR) is a critical regulatory segment of the GAB2 transcript that controls protein abundance through post-transcriptional mechanisms. GAB2 itself serves as a major scaffolding protein that coordinates signaling downstream of various tyrosine kinase receptors, playing a central role in the activation of the PI3K/Akt and Ras/MAPK pathways (Source: UniProt). The 3'-UTR contains multiple binding sites for microRNAs (miRNAs), such as miR-125b and miR-200c, which typically function to destabilize the mRNA or inhibit its translation (Source: PubMed, Journal of Biological Chemistry). In many cancers, including breast cancer and chronic myeloid leukemia, the downregulation of these regulatory miRNAs leads to GAB2 overexpression, which drives tumor cell proliferation, survival, and metastasis (Source: Cancer Research). Furthermore, specific polymorphisms within the GAB2 3'-UTR have been identified as significant genetic modifiers of Alzheimer's disease risk, likely by altering the expression of GAB2 in the brain and influencing Tau protein phosphorylation (Source: Neuron, NIH). Therapeutic strategies targeting this region involve the use of miRNA mimics or antisense oligonucleotides (ASOs) designed to restore normal GAB2 levels and inhibit disease progression.

Other names

GAB2 3'-UTRGRB2-associated-binding protein 2 3'-UTRGAB2 3-prime untranslated regionGAB2 3' untranslated region

Therapeutic agents such as miRNA mimics or antisense oligonucleotides bind to specific sequences within the 3'-UTR to induce mRNA degradation via the RISC complex or RNase H, or to sterically hinder the translation machinery, thereby reducing the expression of the GAB2 protein.